The Therapeutic Role of Interferons and Monoclonal Antibodies in Cutaneous T-Cell Lymphomas
- 1 December 1990
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 95 (6) , S209-S212
- https://doi.org/10.1111/1523-1747.ep12875762
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell LymphomaJNCI Journal of the National Cancer Institute, 1990
- Interferon Alfa-2a Combined With Phototherapy in the Treatment of Cutaneous T-Cell LymphomaJNCI Journal of the National Cancer Institute, 1990
- Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.Journal of Clinical Oncology, 1990
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989
- Interferon alfa-2a in the treatment of cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Treatment of mycosis fungoides with recombinant interferon-αza2 alone and in combination with etretinateBritish Journal of Dermatology, 1988
- Recombinant Interferon Alfa-2b in Plaque-Phase Mycosis FungoidesArchives of Dermatology, 1987
- Radioimmunodetection of Cutaneous T-Cell Lymphoma with111In-Labeled T101 Monoclonal AntibodyNew England Journal of Medicine, 1986
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981
- Phenotypic Characterization of Cutaneous T-Cell LymphomaNew England Journal of Medicine, 1981